India's Pharma Industry Faces Profit Squeeze Amid Weak Rupee and Slowing Exports
Hızlı Bakış
- India's pharmaceutical sector is hit by rising import costs due to a weaker rupee and declining export demand from a global economic slowdown, squeezing manufacturer profits.
- Companies are shifting to higher-margin products to cope.
Yapay zekâ özeti
India's pharmaceutical sector is hit by rising import costs due to a weaker rupee and declining export demand from a global economic slowdown, squeezing manufacturer profits. Companies are shifting to higher-margin products to cope.